Vigilant Software Suite – Vigilant Master Med
Infusion Safety Management Software. 510(k) K210075, from Fresenius Kabi AG (Bad Homburg, DE). Product code PHC, class 2.
As of Nov 20, 2026, K210075 is an FDA 510(k) held by Fresenius Kabi AG, substantially equivalent on Mar 1, 2022 after 413 days, with no recalls tied to it in FDA's recall database.
- Review time: 413 days
- Recalls: 0
Vigilant Master Med is part of a Dose Error Reduction System (DERS) for use with Adults, Pediatrics, and Neonates. It is intended to create, customize, and manage drug library data and device configurations to be uploaded to compatible Fresenius Kabi infusion devices which may reduce the risk of drug administration errors.
- Agilia Infusion SystemK121613 · Fresenius Kabi AG · May 1, 2013
- LifeShield Infusion Safety Software SuiteK252130 · Icu Medical, Inc. · Apr 2, 2026
- BD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD Intelliport Gateway (516232);…K243062 · Becton Dickinson · Jun 20, 2025
- LifeShield Infusion Safety Software SuiteK242117 · Icu Medical, Inc. · Apr 2, 2025
- Dose IQ Safety SoftwareK230665 · Baxter Healthcare Corporation · Mar 29, 2024
- LifeShield™ Infusion Safety Software SuiteK223606 · Icu Medical, Inc. · Aug 24, 2023
- Dose IQ Safety SoftwareK211124 · Baxter Healthcare Corporation · Aug 30, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 12, 2021
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5725
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files